ER780 Anti-Human CD11b Antibody[ICRF44]

The ER780 Anti-Human CD11b Antibody[ICRF44] is a highly specific and reliable tool designed for the detection and analysis of CD11b expression in human samples. This monoclonal antibody, produced through advanced technology, exhibits exceptional affinity and selectivity towards CD11b, a cell surface glycoprotein primarily expressed on myeloid cells.

With its superior performance, the ER780 Anti-Human CD11b Antibody[ICRF44] enables accurate identification and quantification of CD11b-positive cells in various research applications, including immunohistochemistry, flow cytometry, and western blotting. Its exceptional sensitivity and low background staining ensure precise and reproducible results, facilitating robust data interpretation.

This antibody's exceptional specificity towards CD11b allows for reliable discrimination between CD11b-positive and CD11b-negative cells, contributing to the elucidation of cellular functions and interactions in diverse biological systems. Moreover, its compatibility with multiple sample types, including blood, bone marrow, and tissue sections, enhances its versatility and applicability in various experimental settings.

The ER780 Anti-Human CD11b Antibody[ICRF44] is a valuable asset for researchers and scientists seeking to investigate the role of CD11b in immune responses, inflammation, and various pathological conditions. Its high quality, consistency, and performance make it an indispensable tool for advancing scientific knowledge and contributing to the development of novel therapeutic strategies.